Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BPaLMZ Regimen for Tuberculous Meningitis
NCT07227779Phase 2Recruiting
- Start
- Jul 2026
- Primary completion
- Mar 2028
- Modality
- Prodrugs/Conditional Activator Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bedaquiline, pretomanid, linezolid, moxifloxacin in tuberculous meningitis (TBM). Started Jul 2026; status: recruiting.
02
Drugs
bedaquilinepretomanidlinezolidmoxifloxacin
03
Conditions
tuberculous meningitis (TBM)
Beyond the preview
Go deeper on NCT07227779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07227779.